Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of oral HPP737 in adults with moderate to severe plaque psoriasis
CTR20230475Phase 3Completed
- Sponsor
- Hengyi Biopharmaceutical
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HPP737 in plaque psoriasis, sponsored by Hengyi Biopharmaceutical. Started Apr 2023; status: completed.
02
Drugs
HPP737
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20230475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230475.